MAPT and Alzheimer disease: Over-activation of GSK-3 is implicated in several processes associated with AD, such as tau hyperphosphorylation, increase of β-amyloid plaques production, microglia activation, neurofibrillary tangle formation, and cell apoptosis3,.4